<DOC>
	<DOCNO>NCT02093377</DOCNO>
	<brief_summary>The aim randomize control trial test effect 12 week Adaptive Servo-Ventilation ( ASV ) therapy ( additionally optimal medical management myocardial infarction ) myocardial salvage ( MSI=myocardial salvage/area risk , primary endpoint ) .</brief_summary>
	<brief_title>ASV Sleep Apnea After Myocardial Infarction</brief_title>
	<detailed_description>Primary Outcome Measure : myocardial salvage index , MSI - To test effect 12 week ASV ( additionally percutaneous coronary intervention , PCI , optimal medical management AMI ) myocardial salvage ( myocardial salvage index , MSI , assess cardiovascular magnetic resonance imaging , CMR ) . Secondary Outcome Measures : - To test whether ASV therapy patient SA early AMI decrease infarct size improve leave ventricular remodelling ( myocardial salvage , microvascular obstruction change infarct size , infarct size 12 week , change leave ventricular ejection fraction ( LVEF ) , leave ventricular systolic volume ( LVSV ) , leave ventricular diastolic volume ( LVDV ) LVEF 12 week ; assess CMR ) . B-type natriuretic peptide ( NT-proBNP ) - To test whether ASV therapy patient SA early AMIimproves disease specific symptom burden ( Seattle Angina Questionnaire ) - To test whether ASV therapy patient sleep apnea early AMI suppress sleep apnea ( apneas hypopneas/hour sleep , mean oxygen saturation ) . - To test whether ASV therapy patient sleep apnea early AMI increase renal function ( Glomerular Filtration Rate , calculate use 4vMDRD formula ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>1. age 1880 year 2. first AMI ( STelevation ECG acute occlusion coronary artery ) 3 . Primary successful PCI achieve &lt; 24 h symptom onset 4 . SA AHI &gt; =15 per hour recording time 5. write informed consent Exclusion criterion : 1. previous myocardial infarction 2. previous myocardial revascularization ( PCI surgical ) 3 . LVEF &lt; 45 % central sleep apnea 4. indication surgical revascularisation 5. cardiogenic shock , mean supine blood pressure &lt; 60mmHg NYHA class IV 6. implant cardiac device contraindication CMR 7. know allergy contraindication contrast medium ( e.g . GFR &lt; 30ml/min/1.73mÂ² ) 8. history stroke 9. contraindication positive airway pressure support ( hypotension mean supine BP &lt; 60mmHg , dehydration , inability clear secretion , patient risk aspiration gastric content , severe bullous lung disease , history pneumothorax and/or pneumomediastinum , history epistaxis , cause pulmonary aspiration blood , cerebrospinal fluid leak recent skull operation injury ) patient indication oxygen therapy , mechanical/noninvasive ventilation 10. patient nocturnal positive airway pressure support 11. severe obstructive restrictive airway disease 12. heart failure due primary valve disease 13. patient await heart transplantation 14. diurnal symptom OSA require immediate treatment 15. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>acute myocardial infarction</keyword>
	<keyword>sleep apnea</keyword>
	<keyword>adaptive servo-ventilation</keyword>
</DOC>